These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30044380)

  • 1. Comparative Study of Carborane- and Phenyl-Modified Adenosine Derivatives as Ligands for the A2A and A3 Adenosine Receptors Based on a Rigid in Silico Docking and Radioligand Replacement Assay.
    Vincenzi M; Bednarska K; Leśnikowski ZJ
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30044380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel adenosine receptor ligands based on the 3-amidocoumarin scaffold.
    Matos MJ; Vilar S; Kachler S; Celeiro M; Vazquez-Rodriguez S; Santana L; Uriarte E; Hripcsak G; Borges F; Klotz KN
    Bioorg Chem; 2015 Aug; 61():1-6. PubMed ID: 26042529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of adenosine derivatives as A
    Bednarska-Szczepaniak K; Mieczkowski A; Kierozalska A; Pavlović Saftić D; Głąbała K; Przygodzki T; Stańczyk L; Karolczak K; Watała C; Rao H; Gao ZG; Jacobson KA; Leśnikowski ZJ
    Eur J Med Chem; 2021 Nov; 223():113607. PubMed ID: 34171656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of truncated C2- or C8-substituted adenosine derivatives as dual acting A₂A and A₃ adenosine receptor ligands.
    Hou X; Majik MS; Kim K; Pyee Y; Lee Y; Alexander V; Chung HJ; Lee HW; Chandra G; Lee JH; Park SG; Choi WJ; Kim HO; Phan K; Gao ZG; Jacobson KA; Choi S; Lee SK; Jeong LS
    J Med Chem; 2012 Jan; 55(1):342-56. PubMed ID: 22142423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
    Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G
    J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel thiazole-thiophene conjugates as adenosine receptor antagonists: synthesis, biological evaluation and docking studies.
    Pandya DH; Sharma JA; Jalani HB; Pandya AN; Sudarsanam V; Kachler S; Klotz KN; Vasu KK
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1306-9. PubMed ID: 25686851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Taxicab geometry quantification system to evaluate the performance of in silico methods: a case study on adenosine receptors ligands.
    Kuder KJ; Michalik I; Kieć-Kononowicz K; Kolb P
    J Comput Aided Mol Des; 2020 Jun; 34(6):697-707. PubMed ID: 32112287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor.
    Kim SK; Gao ZG; Jeong LS; Jacobson KA
    J Mol Graph Model; 2006 Dec; 25(4):562-77. PubMed ID: 16793299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: insight into the receptor activation switch.
    Dal Ben D; Buccioni M; Lambertucci C; Kachler S; Falgner N; Marucci G; Thomas A; Cristalli G; Volpini R; Klotz KN
    Biochem Pharmacol; 2014 Jan; 87(2):321-31. PubMed ID: 24161786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds.
    van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; Ijzerman AP
    J Med Chem; 1998 Oct; 41(21):3994-4000. PubMed ID: 9767637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight into the interactions between novel coumarin derivatives and human A3 adenosine receptors.
    Matos MJ; Vilar S; Kachler S; Fonseca A; Santana L; Uriarte E; Borges F; Tatonetti NP; Klotz KN
    ChemMedChem; 2014 Oct; 9(10):2245-53. PubMed ID: 25044491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.
    van Tilburg EW; van der Klein PA; von Frijtag Drabbe Künzel J; de Groote M; Stannek C; Lorenzen A; IJzerman AP
    J Med Chem; 2001 Aug; 44(18):2966-75. PubMed ID: 11520205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
    Yuzlenko O; Kieć-Kononowicz K
    J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of N⁶-substituted apioadenosines as potential adenosine A₃ receptor modulators.
    Toti KS; Moss SM; Paoletta S; Gao ZG; Jacobson KA; Van Calenbergh S
    Bioorg Med Chem; 2014 Aug; 22(15):4257-68. PubMed ID: 24931275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine Receptor Ligands: Coumarin-Chalcone Hybrids as Modulating Agents on the Activity of
    Vazquez-Rodriguez S; Vilar S; Kachler S; Klotz KN; Uriarte E; Borges F; Matos MJ
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32961824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Probing and Molecular Modeling of the A₃ Adenosine Receptor: A Focus on Agonist Binding.
    Ciancetta A; Jacobson KA
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28287473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of 2-hydrazinyladenosine derivatives as A
    Zhang M; Fan S; Zhou X; Xie F; Li S; Zhong W
    Eur J Med Chem; 2019 Oct; 179():310-324. PubMed ID: 31255928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling study on potent and selective adenosine A(3) receptor agonists.
    Dal Ben D; Buccioni M; Lambertucci C; Marucci G; Thomas A; Volpini R; Cristalli G
    Bioorg Med Chem; 2010 Nov; 18(22):7923-30. PubMed ID: 20943397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5'-C-Ethyl-tetrazolyl-N(6)-substituted adenosine and 2-chloro-adenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists.
    Petrelli R; Torquati I; Kachler S; Luongo L; Maione S; Franchetti P; Grifantini M; Novellino E; Lavecchia A; Klotz KN; Cappellacci L
    J Med Chem; 2015 Mar; 58(5):2560-6. PubMed ID: 25699637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel class of adenosine A3 receptor ligands. 1. 3-(2-Pyridinyl)isoquinoline derivatives.
    van Muijlwijk-Koezen JE; Timmerman H; Link R; van der Goot H; IJzerman AP
    J Med Chem; 1998 Oct; 41(21):3987-93. PubMed ID: 9767636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.